GL1X · GenesisL1 explorer

Research workbench

Oxa-23 mutant F110A/M221A neutral pH form meropenem complex

Analyse Oxa-23 mutant F110A/M221A neutral pH form meropenem complex in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6N6Y
Type
protein
Length
238 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase OXA23
EC
3.5.2.6
UniProt
Q9L4P2
Ligands
KE1
Pockets
1 · best druggability 0.36

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase OXA23 (EC 3.5.2.6)protein23837% helix, 19% strandQ9L4P2

Ligands and binding sites

  • KE1 · meropenem, bound form · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11180.360.7320KE1

Modifications

Observed in the structure: 1 covalent, 1 modified (covalent ligand, carboxylation).

Compared structures

  • 6N6Y · OXA-23 mutant F110A/M221A neutral pH form meropenem complex · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.